Collection of Biological Specimens and Associated Health Information for Secondary Research in Future Studies

Ovation.io, Inc.1 site in 1 country10,000 target enrollmentApril 2024

ConditionsCancer Other Disease

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Cancer
Sponsor: Ovation.io, Inc.
Enrollment: 10000
Locations: 1
Primary Endpoint: Biorepository
Status: Not yet recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to collect blood samples from a large number of individuals with cancer to create a database for researchers to use in future studies. Researchers may use this database to discover new ways to detect and treat cancer and other diseases. Future studies may use stored blood samples to discover how genes affect health and disease.

Registry

clinicaltrials.gov

Start Date

April 2024

End Date

April 2034

Last Updated

2 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Ovation.io, Inc.

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Are patients of participating study site clinics/clinical groups
•Are adults (aged 18 or older)
•Have an active cancer diagnosis with confirmatory pathology results indicating solid tumor and/or hematologic malignancy
•Participants may have other active diagnoses with confirmatory clinical results

Exclusion Criteria

•Individuals who lack the capacity to provide informed consent
•Individuals known to be prisoners at time of biological specimen collection

Outcomes

Primary Outcomes

Biorepository

Time Frame: 10 years

The objective of this study is to establish a biorepository and database of specimens to enable future research on the role of genetic factors in the biological mechanisms of diseases, including cancer, and treatment outcomes.